<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37501540</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-3178</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>06</Day></PubDate></JournalIssue><Title>EMBO reports</Title><ISOAbbreviation>EMBO Rep</ISOAbbreviation></Journal><ArticleTitle>UBQLN2 and HSP70 participate in Parkin-mediated mitophagy by facilitating outer mitochondrial membrane rupture.</ArticleTitle><Pagination><StartPage>e55859</StartPage><MedlinePgn>e55859</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e55859</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.15252/embr.202255859</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two aging-related neurodegenerative diseases that share common key features, including aggregation of pathogenic proteins, dysfunction of mitochondria, and impairment of autophagy. Mutations in ubiquilin 2 (UBQLN2), a shuttle protein in the ubiquitin-proteasome system (UPS), can cause ALS/FTD, but the mechanism underlying UBQLN2-mediated pathogenesis is still uncertain. Recent studies indicate that mitophagy, a selective form of autophagy which is crucial for mitochondrial quality control, is tightly associated with neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and ALS. In this study, we show that after Parkin-dependent ubiquitination of damaged mitochondria, UBQLN2 is recruited to poly-ubiquitinated mitochondria through the UBA domain. UBQLN2 cooperates with the chaperone HSP70 to promote UPS-driven degradation of outer mitochondrial membrane (OMM) proteins. The resulting rupture of the OMM triggers the autophagosomal recognition of the inner mitochondrial membrane receptor PHB2. UBQLN2 is required for Parkin-mediated mitophagy and neuronal survival upon mitochondrial damage, and the ALS/FTD pathogenic mutations in UBQLN2 impair mitophagy in primary cultured neurons. Taken together, our findings link dysfunctional mitophagy to UBQLN2-mediated neurodegeneration.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Qilian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology &amp; Medical Physics and FUTURE-NEURO Research Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xin</LastName><ForeName>Jiaqi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ningning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Shan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health Sciences, University of Macau, Macau, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Hongyu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Guoqiang</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-0475-3267</Identifier><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Nana</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tam</LastName><ForeName>Kin Yip</ForeName><Initials>KY</Initials><Identifier Source="ORCID">0000-0001-5507-8524</Identifier><AffiliationInfo><Affiliation>Faculty of Health Sciences, University of Macau, Macau, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dussmann</LastName><ForeName>Heiko</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-3582-8057</Identifier><AffiliationInfo><Affiliation>Department of Physiology &amp; Medical Physics and FUTURE-NEURO Research Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prehn</LastName><ForeName>Jochen Hm</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0003-3479-7794</Identifier><AffiliationInfo><Affiliation>Department of Physiology &amp; Medical Physics and FUTURE-NEURO Research Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hongfeng</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-4909-2260</Identifier><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ying</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-1099-0509</Identifier><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EMBO Rep</MedlineTA><NlmUniqueID>100963049</NlmUniqueID><ISSNLinking>1469-221X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071183">Autophagy-Related Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.25.1</RegistryNumber><NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025801">Ubiquitin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C405662">UBQLN2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051336" MajorTopicYN="N">Mitochondrial Membranes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063306" MajorTopicYN="N">Mitophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071183" MajorTopicYN="N">Autophagy-Related Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046988" MajorTopicYN="N">Proteasome Endopeptidase Complex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D025801" MajorTopicYN="N">Ubiquitin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="N">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Parkin</Keyword><Keyword MajorTopicYN="N">UBQLN2</Keyword><Keyword MajorTopicYN="N">mitophagy</Keyword><Keyword MajorTopicYN="N">ubiquitin</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>3</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37501540</ArticleId><ArticleId IdType="pmc">PMC10481660</ArticleId><ArticleId IdType="doi">10.15252/embr.202255859</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adegoke OO, Qiao F, Liu Y, Longley K, Feng S, Wang H (2017) Overexpression of ubiquilin&#x2010;1 alleviates Alzheimer's disease&#x2010;caused cognitive and motor deficits and reduces amyloid&#x2010;beta accumulation in mice. J Alzheimers Dis 59: 575&#x2013;590</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5791527</ArticleId><ArticleId IdType="pubmed">28598849</ArticleId></ArticleIdList></Reference><Reference><Citation>An H, Harper JW (2018) Systematic analysis of ribophagy in human cells reveals bystander flux during selective autophagy. Nat Cell Biol 20: 135&#x2013;143</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5786475</ArticleId><ArticleId IdType="pubmed">29230017</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan NC, Salazar AM, Pham AH, Sweredoski MJ, Kolawa NJ, Graham RL, Hess S, Chan DC (2011) Broad activation of the ubiquitin&#x2010;proteasome system by Parkin is critical for mitophagy. Hum Mol Genet 20: 1726&#x2013;1737</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071670</ArticleId><ArticleId IdType="pubmed">21296869</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Gao F, Li B, Wang H, Xu Y, Zhu C, Wang G (2010) Parkin mono&#x2010;ubiquitinates Bcl&#x2010;2 and regulates autophagy. J Biol Chem 285: 38214&#x2013;38223</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2992255</ArticleId><ArticleId IdType="pubmed">20889974</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Li YP, Yu YX, Zhou T, Liu C, Fei EK, Gao F, Mu CC, Ren HG, Wang GH (2018) Dendritic cell nuclear protein&#x2010;1 regulates melatonin biosynthesis by binding to BMAL1 and inhibiting the transcription of N&#x2010;acetyltransferase in C6 cells. Acta Pharmacol Sin 39: 597&#x2013;606</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5888688</ArticleId><ArticleId IdType="pubmed">29219947</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, Siddique N, Yang Y, Fecto F, Shi Y, Zhai H et&#xa0;al (2011) Mutations in UBQLN2 cause dominant X&#x2010;linked juvenile and adult&#x2010;onset ALS and ALS/dementia. Nature 477: 211&#x2013;215</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans CS, Holzbaur ELF (2020) Lysosomal degradation of depolarized mitochondria is rate&#x2010;limiting in OPTN&#x2010;dependent neuronal mitophagy. Autophagy 16: 962&#x2013;964</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7144876</ArticleId><ArticleId IdType="pubmed">32131674</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahed AC, McDonough B, Gouvion CM, Newell KL, Dure LS, Bebin M, Bick AG, Seidman JG, Harter DH, Seidman CE (2014) UBQLN2 mutation causing heterogeneous X&#x2010;linked dominant neurodegeneration. Ann Neurol 75: 793&#x2013;798</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4106259</ArticleId><ArticleId IdType="pubmed">24771548</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang LM, Li B, Guan JJ, Xu HD, Shen GH, Gao QG, Qin ZH (2017) Transcription factor EB is involved in autophagy&#x2010;mediated chemoresistance to doxorubicin in human cancer cells. Acta Pharmacol Sin 38: 1305&#x2013;1316</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5589965</ArticleId><ArticleId IdType="pubmed">28603284</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang EF, Hou Y, Palikaras K, Adriaanse BA, Kerr JS, Yang B, Lautrup S, Hasan&#x2010;Olive MM, Caponio D, Dan X et&#xa0;al (2019) Mitophagy inhibits amyloid&#x2010;beta and tau pathology and reverses cognitive deficits in models of Alzheimer's disease. Nat Neurosci 22: 401&#x2013;412</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6693625</ArticleId><ArticleId IdType="pubmed">30742114</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleming A, Bourdenx M, Fujimaki M, Karabiyik C, Krause GJ, Lopez A, Puri C, Scrivo A, Skidmore J, Son SM et&#xa0;al (2022) The different autophagy degradation pathways and neurodegeneration. Neuron 110: 935&#x2013;966</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8930707</ArticleId><ArticleId IdType="pubmed">35134347</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladkova C, Maslen SL, Skehel JM, Komander D (2018) Mechanism of parkin activation by PINK1. Nature 559: 410&#x2013;414</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6071873</ArticleId><ArticleId IdType="pubmed">29995846</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo DK, Zhu Y, Sun HY, Xu XY, Zhang S, Hao ZB, Wang GH, Mu CC, Ren HG (2019) Pharmacological activation of REV&#x2010;ERBalpha represses LPS&#x2010;induced microglial activation through the NF&#x2010;kappaB pathway. Acta Pharmacol Sin 40: 26&#x2013;34</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6318300</ArticleId><ArticleId IdType="pubmed">29950615</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding O, Evans CS, Ye J, Cheung J, Maniatis T, Holzbaur ELF (2021) ALS&#x2010; and FTD&#x2010;associated missense mutations in TBK1 differentially disrupt mitophagy. Proc Natl Acad Sci USA 118: e2025053118</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8214690</ArticleId><ArticleId IdType="pubmed">34099552</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper JW, Ordureau A, Heo JM (2018) Building and decoding ubiquitin chains for mitophagy. Nat Rev Mol Cell Biol 19: 93&#x2013;108</Citation><ArticleIdList><ArticleId IdType="pubmed">29358684</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo JM, Ordureau A, Paulo JA, Rinehart J, Harper JW (2015) The PINK1&#x2010;PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol Cell 60: 7&#x2013;20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4592482</ArticleId><ArticleId IdType="pubmed">26365381</ArticleId></ArticleIdList></Reference><Reference><Citation>Herhaus L, Bhaskara RM, Lystad AH, Gestal&#x2010;Mato U, Covarrubias&#x2010;Pinto A, Bonn F, Simonsen A, Hummer G, Dikic I (2020) TBK1&#x2010;mediated phosphorylation of LC3C and GABARAP&#x2010;L2 controls autophagosome shedding by ATG4 protease. EMBO Rep 21: e48317</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6945063</ArticleId><ArticleId IdType="pubmed">31709703</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjerpe R, Bett JS, Keuss MJ, Solovyova A, McWilliams TG, Johnson C, Sahu I, Varghese J, Wood N, Wightman M et&#xa0;al (2016) UBQLN2 mediates autophagy&#x2010;independent protein aggregate clearance by the proteasome. Cell 166: 935&#x2013;949</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003816</ArticleId><ArticleId IdType="pubmed">27477512</ArticleId></ArticleIdList></Reference><Reference><Citation>Itakura E, Zavodszky E, Shao S, Wohlever ML, Keenan RJ, Hegde RS (2016) Ubiquilins chaperone and triage mitochondrial membrane proteins for degradation. Mol Cell 63: 21&#x2013;33</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4942676</ArticleId><ArticleId IdType="pubmed">27345149</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane LA, Lazarou M, Fogel AI, Li Y, Yamano K, Sarraf SA, Banerjee S, Youle RJ (2014) PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J Cell Biol 205: 143&#x2013;153</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4003245</ArticleId><ArticleId IdType="pubmed">24751536</ArticleId></ArticleIdList></Reference><Reference><Citation>Katayama H, Kogure T, Mizushima N, Yoshimori T, Miyawaki A (2011) A sensitive and quantitative technique for detecting autophagic events based on lysosomal delivery. Chem Biol 18: 1042&#x2013;1052</Citation><ArticleIdList><ArticleId IdType="pubmed">21867919</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye FJ, Modi S, Ivanovska I, Koonin EV, Thress K, Kubo A, Kornbluth S, Rose MD (2000) A family of ubiquitin&#x2010;like proteins binds the ATPase domain of Hsp70&#x2010;like Stch. FEBS Lett 467: 348&#x2013;355</Citation><ArticleIdList><ArticleId IdType="pubmed">10675567</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazlauskaite A, Kondapalli C, Gourlay R, Campbell DG, Ritorto MS, Hofmann K, Alessi DR, Knebel A, Trost M, Muqit MM (2014) Parkin is activated by PINK1&#x2010;dependent phosphorylation of ubiquitin at Ser65. Biochem J 460: 127&#x2013;139</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4000136</ArticleId><ArticleId IdType="pubmed">24660806</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr JS, Adriaanse BA, Greig NH, Mattson MP, Cader MZ, Bohr VA, Fang EF (2017) Mitophagy and Alzheimer's disease: cellular and molecular mechanisms. Trends Neurosci 40: 151&#x2013;166</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5341618</ArticleId><ArticleId IdType="pubmed">28190529</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim NC, Tresse E, Kolaitis RM, Molliex A, Thomas RE, Alami NH, Wang B, Joshi A, Smith RB, Ritson GP et&#xa0;al (2013) VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations. Neuron 78: 65&#x2013;80</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3683300</ArticleId><ArticleId IdType="pubmed">23498974</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyano F, Okatsu K, Kosako H, Tamura Y, Go E, Kimura M, Kimura Y, Tsuchiya H, Yoshihara H, Hirokawa T et&#xa0;al (2014) Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 510: 162&#x2013;166</Citation><ArticleIdList><ArticleId IdType="pubmed">24784582</ArticleId></ArticleIdList></Reference><Reference><Citation>Lautrup S, Sinclair DA, Mattson MP, Fang EF (2019) NAD+ in brain aging and neurodegenerative disorders. Cell Metab 30: 630&#x2013;655</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6787556</ArticleId><ArticleId IdType="pubmed">31577933</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarou M, Jin SM, Kane LA, Youle RJ (2012) Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase Parkin. Dev Cell 22: 320&#x2013;333</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3288275</ArticleId><ArticleId IdType="pubmed">22280891</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL, Sideris DP, Fogel AI, Youle RJ (2015) The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524: 309&#x2013;314</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5018156</ArticleId><ArticleId IdType="pubmed">26266977</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang JR, Martinez A, Lane JD, Mayor U, Clague MJ, Urbe S (2015) USP30 deubiquitylates mitochondrial Parkin substrates and restricts apoptotic cell death. EMBO Rep 16: 618&#x2013;627</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4428036</ArticleId><ArticleId IdType="pubmed">25739811</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79: 416&#x2013;438</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou G, Palikaras K, Lautrup S, Scheibye&#x2010;Knudsen M, Tavernarakis N, Fang EF (2020) Mitophagy and neuroprotection. Trends Mol Med 26: 8&#x2013;20</Citation><ArticleIdList><ArticleId IdType="pubmed">31375365</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson MP, Gleichmann M, Cheng A (2008) Mitochondria in neuroplasticity and neurological disorders. Neuron 60: 748&#x2013;766</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2692277</ArticleId><ArticleId IdType="pubmed">19081372</ArticleId></ArticleIdList></Reference><Reference><Citation>Michel MA, Swatek KN, Hospenthal MK, Komander D (2017) Ubiquitin linkage&#x2010;specific affimers reveal insights into K6&#x2010;linked ubiquitin signaling. Mol Cell 68: 233&#x2013;246</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5640506</ArticleId><ArticleId IdType="pubmed">28943312</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore AS, Holzbaur EL (2016) Dynamic recruitment and activation of ALS&#x2010;associated TBK1 with its target optineurin are required for efficient mitophagy. Proc Natl Acad Sci USA 113: E3349&#x2013;E3358</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4914160</ArticleId><ArticleId IdType="pubmed">27247382</ArticleId></ArticleIdList></Reference><Reference><Citation>Narendra D, Tanaka A, Suen DF, Youle RJ (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183: 795&#x2013;803</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2592826</ArticleId><ArticleId IdType="pubmed">19029340</ArticleId></ArticleIdList></Reference><Reference><Citation>Narendra D, Kane LA, Hauser DN, Fearnley IM, Youle RJ (2010) p62/SQSTM1 is required for Parkin&#x2010;induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both. Autophagy 6: 1090&#x2013;1106</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3359490</ArticleId><ArticleId IdType="pubmed">20890124</ArticleId></ArticleIdList></Reference><Reference><Citation>Ordureau A, Sarraf SA, Duda DM, Heo JM, Jedrychowski MP, Sviderskiy VO, Olszewski JL, Koerber JT, Xie T, Beausoleil SA et&#xa0;al (2014) Quantitative proteomics reveal a feedforward mechanism for mitochondrial PARKIN translocation and ubiquitin chain synthesis. Mol Cell 56: 360&#x2013;375</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4254048</ArticleId><ArticleId IdType="pubmed">25284222</ArticleId></ArticleIdList></Reference><Reference><Citation>Ordureau A, Paulo JA, Zhang J, An H, Swatek KN, Cannon JR, Wan Q, Komander D, Harper JW (2020) Global landscape and dynamics of Parkin and USP30&#x2010;dependent ubiquitylomes in ineurons during mitophagic signaling. Mol Cell 77: 1124&#x2013;1142</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7098486</ArticleId><ArticleId IdType="pubmed">32142685</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaka M, Ito D, Yagi T, Nihei Y, Suzuki N (2015) Evidence of a link between ubiquilin 2 and optineurin in amyotrophic lateral sclerosis. Hum Mol Genet 24: 1617&#x2013;1629</Citation><ArticleIdList><ArticleId IdType="pubmed">25398946</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S, Vigie P, Youle RJ (2018) Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr Biol 28: R170&#x2013;R185</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255410</ArticleId><ArticleId IdType="pubmed">29462587</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickrell AM, Youle RJ (2015) The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease. Neuron 85: 257&#x2013;273</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4764997</ArticleId><ArticleId IdType="pubmed">25611507</ArticleId></ArticleIdList></Reference><Reference><Citation>Puri R, Cheng X&#x2010;T, Lin M&#x2010;Y, Huang N, Sheng Z&#x2010;H (2019) Mul1 restrains Parkin&#x2010;mediated mitophagy in mature neurons by maintaining ER&#x2010;mitochondrial contacts. Nat Commun 10: 3645</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6692330</ArticleId><ArticleId IdType="pubmed">31409786</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakovic A, Ziegler J, Martensson CU, Prasuhn J, Shurkewitsch K, Konig P, Paulson HL, Klein C (2019) PINK1&#x2010;dependent mitophagy is driven by the UPS and can occur independently of LC3 conversion. Cell Death Differ 26: 1428&#x2013;1441</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6748138</ArticleId><ArticleId IdType="pubmed">30375512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren ZX, Zhao YF, Cao T, Zhen XC (2016) Dihydromyricetin protects neurons in an MPTP&#x2010;induced model of Parkinson's disease by suppressing glycogen synthase kinase&#x2010;3 beta activity. Acta Pharmacol Sin 37: 1315&#x2013;1324</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5057232</ArticleId><ArticleId IdType="pubmed">27374489</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud L, Picher&#x2010;Martel V, Codron P, Julien JP (2019) Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia. Acta Neuropathol Commun 7: 103</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6889556</ArticleId><ArticleId IdType="pubmed">31319884</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter B, Sliter DA, Herhaus L, Stolz A, Wang C, Beli P, Zaffagnini G, Wild P, Martens S, Wagner SA et&#xa0;al (2016) Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc Natl Acad Sci USA 113: 4039&#x2013;4044</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4839414</ArticleId><ArticleId IdType="pubmed">27035970</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauve V, Sung G, Soya N, Kozlov G, Blaimschein N, Miotto LS, Trempe JF, Lukacs GL, Gehring K (2018) Mechanism of parkin activation by phosphorylation. Nat Struct Mol Biol 25: 623&#x2013;630</Citation><ArticleIdList><ArticleId IdType="pubmed">29967542</ArticleId></ArticleIdList></Reference><Reference><Citation>Senturk M, Lin G, Zuo ZY, Mao DX, Watson E, Mikos AG, Bellen HJ (2019) Ubiquilins regulate autophagic flux through mTOR signalling and lysosomal acidification. Nat Cell Biol 21: 384&#x2013;396</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6534127</ArticleId><ArticleId IdType="pubmed">30804504</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun N, Malide D, Liu J, Rovira II, Combs CA, Finkel T (2017) A fluorescence&#x2010;based imaging method to measure in vitro and in vivo mitophagy using mt&#x2010;Keima. Nat Protoc 12: 1576&#x2013;1587</Citation><ArticleIdList><ArticleId IdType="pubmed">28703790</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, Hou H, Ma G, Ma Q, Li N, Zhang L, Dong C, Cao M, Tam KY, Ying Z et&#xa0;al (2022) The interaction between E3 ubiquitin ligase Parkin and mitophagy receptor PHB2 links inner mitochondrial membrane ubiquitination to efficient mitophagy. J Biol Chem 298: 102704</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9763867</ArticleId><ArticleId IdType="pubmed">36379251</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH Jr, Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nature 539: 197&#x2013;206</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Teyssou E, Chartier L, Amador MD, Lam R, Lautrette G, Nicol M, Machat S, Da Barroca S, Moigneu C, Mairey M et&#xa0;al (2017) Novel UBQLN2 mutations linked to amyotrophic lateral sclerosis and atypical hereditary spastic paraplegia phenotype through defective HSP70&#x2010;mediated proteolysis. Neurobiol Aging 58: 239.e11&#x2013;239.e20</Citation><ArticleIdList><ArticleId IdType="pubmed">28716533</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogler M, Dinsdale D, Sun XM, Young KW, Butterworth M, Nicotera P, Dyer MJS, Cohen GM (2008) A novel paradigm for rapid ABT&#x2010;737&#x2010;induced apoptosis involving outer mitochondrial membrane rupture in primary leukemia and lymphoma cells. Cell Death Differ 15: 820&#x2013;830</Citation><ArticleIdList><ArticleId IdType="pubmed">18309326</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang ST, Tatman M, Monteiro MJ (2020) Overexpression of UBQLN1 reduces neuropathology in the P497S UBQLN2 mouse model of ALS/FTD. Acta Neuropathol Commun 8: 164</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539388</ArticleId><ArticleId IdType="pubmed">33028421</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y, Chiang WC, Sumpter R Jr, Mishra P, Levine B (2017) Prohibitin 2 is an inner mitochondrial membrane mitophagy receptor. Cell 168: 224&#x2013;238</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5235968</ArticleId><ArticleId IdType="pubmed">28017329</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong YC, Holzbaur EL (2014) Optineurin is an autophagy receptor for damaged mitochondria in parkin&#x2010;mediated mitophagy that is disrupted by an ALS&#x2010;linked mutation. Proc Natl Acad Sci USA 111: E4439&#x2013;E4448</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4210283</ArticleId><ArticleId IdType="pubmed">25294927</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu JC, Qi L, Wang Y, Kegel KB, Yoder J, Difiglia M, Qin ZH, Lin F (2012) The regulation of N&#x2010;terminal Huntingtin (Htt552) accumulation by Beclin1. Acta Pharmacol Sin 33: 743&#x2013;751</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4010368</ArticleId><ArticleId IdType="pubmed">22543707</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu JY, Li M, Cao LJ, Sun ML, Chen D, Ren HG, Xia Q, Tao ZT, Qin ZH, Hu QS et&#xa0;al (2015) Protease Omi cleaving Hax&#x2010;1 protein contributes to&#xa0;OGD/R&#x2010;induced mitochondrial damage in neuroblastoma N2a cells&#xa0;and cerebral injury in MCAO mice. Acta Pharmacol Sin 36: 1043&#x2013;1052</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4561969</ArticleId><ArticleId IdType="pubmed">26299953</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu JJ, Cai A, Greenslade JE, Higgins NR, Fan C, Le NTT, Tatman M, Whiteley AM, Prado MA, Dieriks BV et&#xa0;al (2020) ALS/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function. Proc Natl Acad Sci USA 117: 15230&#x2013;15241</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7334651</ArticleId><ArticleId IdType="pubmed">32513711</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Q, Hu Q, Wang H, Yang H, Gao F, Ren H, Chen D, Fu C, Zheng L, Zhen X et&#xa0;al (2015) Induction of COX&#x2010;2&#x2010;PGE2 synthesis by activation of the MAPK/ERK pathway contributes to neuronal death triggered by TDP&#x2010;43&#x2010;depleted microglia. Cell Death Dis 6: e1702</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4385945</ArticleId><ArticleId IdType="pubmed">25811799</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshii SR, Kishi C, Ishihara N, Mizushima N (2011) Parkin mediates proteasome&#x2010;dependent protein degradation and rupture of the outer mitochondrial membrane. J Biol Chem 286: 19630&#x2013;19640</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3103342</ArticleId><ArticleId IdType="pubmed">21454557</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu YX, Li YP, Gao F, Hu QS, Zhang Y, Chen D, Wang GH (2016) Vitamin K2 suppresses rotenone&#x2010;induced microglial activation in vitro . Acta Pharmacol Sin 37: 1178&#x2013;1189</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5022102</ArticleId><ArticleId IdType="pubmed">27498777</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Fang Q, Wang H, Qi J, Sun S, Liao M, Wu Y, Hu Y, Jiang P, Cheng C et&#xa0;al (2022) Increased mitophagy protects cochlear hair cells from aminoglycoside&#x2010;induced damage. Autophagy 19: 75&#x2013;91</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9809934</ArticleId><ArticleId IdType="pubmed">35471096</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>